NEW YORK (360Dx) – NeoGenomics announced after the close of the market on Thursday that it expects third quarter revenues of approximately $63.1 million, and estimated that hurricanes Harvey and Irma depressed revenues by approximately $1 million.

The estimated Q3 2017 revenues would be a 4 percent increase year over year from Q3 2016 revenues.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.